S05646 Summary:

BILL NOS05646A
 
SAME ASNo same as
 
SPONSORHANNON
 
COSPNSRPARKER, SERRANO
 
MLTSPNSR
 
Amd S364-j, Soc Serv L
 
Requires medical assistance managed care providers to provide coverage for medically necessary prescription drugs and medical supplies.
Go to top    

S05646 Actions:

BILL NOS05646A
 
06/08/2011REFERRED TO HEALTH
06/17/2011AMEND AND RECOMMIT TO HEALTH
06/17/2011PRINT NUMBER 5646A
06/21/2011COMMITTEE DISCHARGED AND COMMITTED TO RULES
06/21/2011ORDERED TO THIRD READING CAL.1481
06/21/2011PASSED SENATE
06/21/2011DELIVERED TO ASSEMBLY
06/21/2011referred to health
01/04/2012died in assembly
01/04/2012returned to senate
01/04/2012REFERRED TO HEALTH
Go to top

S05646 Floor Votes:

There are no votes for this bill in this legislative session.
Go to top

S05646 Text:



 
                STATE OF NEW YORK
        ________________________________________________________________________
 
                                         5646--A
 
                               2011-2012 Regular Sessions
 
                    IN SENATE
 
                                      June 8, 2011
                                       ___________
 
        Introduced  by  Sens.  HANNON, PARKER -- read twice and ordered printed,
          and when printed to be committed to the Committee on Health -- commit-
          tee discharged, bill amended, ordered reprinted as amended and  recom-
          mitted to said committee
 
        AN  ACT  to  amend  the  social  services  law, in relation to requiring

          managed care providers to  provide  coverage  of  medically  necessary
          prescription drugs and medical supplies
 
          The  People of the State of New York, represented in Senate and Assem-
        bly, do enact as follows:
 
     1    Section 1. Subdivision 1 of section 364-j of the social  services  law
     2  is amended by adding a new paragraph (z) to read as follows:
     3    (z)  "Pharmacy  and  therapeutics committee". An independent committee
     4  used by a managed care provider to develop and  manage  a  formulary  or
     5  preferred drug list that operates pursuant to the requirements of subdi-
     6  vision twenty-five of this section.
     7    § 2. Section 364-j of the social services law is amended by adding two
     8  new subdivisions 25 and 26 to read as follows:

     9    25.  Notwithstanding  any  other  provision  of  law  to the contrary,
    10  managed care providers  shall  cover  medically  necessary  prescription
    11  drugs  and  medical  supplies  in accordance with the following require-
    12  ments:
    13    (a) A managed care provider may utilize a formulary or preferred  drug
    14  list  in the administration of this benefit provided that such formulary
    15  shall have been reviewed and approved by  a  pharmacy  and  therapeutics
    16  committee  comprised  of  members from various clinical specialties that
    17  adequately represent the needs of enrollees including, at a minimum, the
    18  following categories of members:
    19    (i) New York state licensed, board certified physician  practicing  in

    20  the community and serving the Medicaid population;
    21    (ii)  New  York  state licensed, board certified specialty physicians,
    22  including, at a minimum:
 
         EXPLANATION--Matter in italics (underscored) is new; matter in brackets
                              [ ] is old law to be omitted.
                                                                   LBD11505-07-1

        S. 5646--A                          2
 
     1    (A) Physician who is board certified in cardiology, and
     2    (B) Physician who is board certified in psychiatry;
     3    (iii)  New York state licensed pharmacist practicing in the community;
     4  and
     5    (iv) at least on a consulting basis, an adequate number of high volume

     6  specialists, including, but not limited to, an HIV  specialist,  defined
     7  as a physician that has met the criteria of:
     8    (A)  The HIV Medicine Association (HIVMA) definition of an HIV-experi-
     9  enced provider, or
    10    (B) HIV Specialist status accorded by  the  American  Academy  of  HIV
    11  Medicine (AAHIVM).
    12    (b)  The  department  of health shall develop standards to ensure that
    13  each managed care provider's pharmacy and therapeutics committee members
    14  come from various clinical  specialties  and  adequately  represent  the
    15  needs  of  plan beneficiaries. A majority of members shall be practicing
    16  physicians or practicing pharmacists licensed pursuant to title eight of

    17  the education law. Such  department  shall  also  develop  standards  to
    18  ensure  a  transparent  process  for  formulary  development which shall
    19  include the opportunity for public comment prior to any changes  to  the
    20  formulary.    Each  managed care provider's committee shall meet no less
    21  frequently than on a quarterly basis. Minutes of the meetings  shall  be
    22  made  available to the public within ten business days after the minutes
    23  are approved.
    24    (c) A managed care  provider  that  adopts  a  formulary  shall  cover
    25  prescription  drugs in all categories and classes for all disease states
    26  and provide a broad range of  therapeutic  options  for  all  USP  model
    27  guidelines  for  formulary  key  drug types and designated drug classes,

    28  including all or substantially all drugs in the antidepressant, atypical
    29  antipsychotic,  antineoplastic,  anticonvulsant,  immunosuppressant  and
    30  anti-retroviral  classes.  A  managed  care  provider shall also cover a
    31  prescription drug when the pharmacy and  therapeutics  committee  deter-
    32  mines  a  drug  is  significantly more clinically effective or safe than
    33  other drugs in the class.
    34    (d) A managed care provider shall provide coverage for not less than a
    35  nine month supply of non-preferred/non-formulary prescription drugs that
    36  were prescribed to the participant to treat a condition that is  treated
    37  on  an  ongoing basis, either with continuous medication or a medication
    38  taken as needed prior to prescription drugs being added to  the  managed

    39  care program or being removed from the formulary.
    40    (e) The prior authorization shall be processed, and a response sent to
    41  the  requesting pharmacist within two business days of submission. Prior
    42  to the completion of the prior authorization process, a plan shall cover
    43  a minimum seventy-two hour supply of the prescribed drug and the pharma-
    44  cist shall be reimbursed for dispensing a seventy-two hour supply to  an
    45  enrollee.
    46    (f) A managed care provider shall only implement reasonable and gener-
    47  ally  acceptable formulary and utilization management including, but not
    48  limited to, prior authorization, step therapy and generic substitutions;
    49  provided such tools are reviewed and approved by the pharmacy and thera-

    50  peutics committee based on the strength of scientific  evidence,  stand-
    51  ards of practice and nationally accepted treatment guidelines.
    52    (g)  Prior  to  removing  a covered drug from its formulary, a managed
    53  care provider must provide at least  sixty  days  notice  to  enrollees,
    54  authorized  prescribers, network pharmacies and pharmacists prior to the
    55  date such change becomes effective.

        S. 5646--A                          3
 
     1    (h) A managed care provider shall review,  through  the  pharmacy  and
     2  therapeutics committee, all drugs that receive approval from the federal
     3  Food  and Drug Administration within ninety days of their release in the
     4  market, and decisions regarding inclusion in any formulary or  preferred

     5  drug  list shall be made within one hundred eighty days of their release
     6  in the market.  Provided, however, that in the case of those drugs which
     7  have received priority expedited review and approval  of  the  Food  and
     8  Drug  Administration,  a  decision  for  inclusion  in  the formulary or
     9  preferred drug list shall be made within ninety days of such approval by
    10  the Food and Drug Administration.
    11    (i) A managed care provider shall be subject  to  and  shall  use  the
    12  grievance  and  appeals process, including the right to external review,
    13  mandated by article forty-nine of the public health law and title 42  of
    14  the  Code of Federal Regulations, Part 438, upon receipt of an appeal of

    15  a denial of a requested prescription drug, including a denial  based  on
    16  step therapy or fail first protocols.
    17    (j) On or before January first, two thousand twelve, the department of
    18  health shall develop standardized drug prior authorization request forms
    19  to  be  utilized  by  healthcare providers, and accepted by managed care
    20  organizations contracted by the state, through secure electronic  trans-
    21  missions.  To  the extent electronic prescribing systems are used, elec-
    22  tronic prior authorization capabilities shall be incorporated  into  the
    23  program.
    24    26.  The  department  of  health  shall prepare a report no later than
    25  eighteen months after the implementation of  any  expansion  of  managed

    26  care  to  a  new  population  and/or  for  new benefits or services. The
    27  department shall post a draft report  on  its  website  and  provide  an
    28  opportunity  for  public comment. The final report shall be submitted to
    29  the governor and the legislature, along with a description of the  proc-
    30  ess provided for public input. The report shall include an assessment of
    31  the following:
    32    (a) the impact of managed care on patient access to care, including an
    33  evaluation  of  any  barriers to use of services, including prescription
    34  drugs, created by the use of  medical  management  or  cost  containment
    35  tools;
    36    (b)  the  impact  of  the  managed  care  expansion  on utilization of
    37  services, quality of care and patient outcomes; and

    38    (c) the use of prior authorization and  other  utilization  management
    39  tools,  including  an  assessment  of  whether these tools pose an undue
    40  administrative burden for physicians and/or create  barriers  to  needed
    41  care.
    42    §  3.  This act shall take effect immediately; provided, however, that
    43  the amendments to section 364-j of  the  social  services  law  made  by
    44  sections  one  and  two  of this act shall not affect the repeal of such
    45  section and shall be deemed repealed therewith.
Go to top